{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibojtc6glriy6nycgfpkyldgwxu3md4bljmul675eq6t5mrvngxya",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlvv4qd4gy72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidzyh5agzs7stt6miyxrtxkcbcubskbfvuda4ybrf27oohf3rnuaa"
    },
    "mimeType": "image/jpeg",
    "size": 279164
  },
  "path": "/news/2026-05-treatment-lassa-fever-clinical-trial.html",
  "publishedAt": "2026-05-15T13:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The infectious disease Lassa fever can be fatal, and there is a lack of treatment options with proven efficacy. Researchers at the Bernhard Nocht Institute for Tropical Medicine (BNITM) and the University Medical Center Hamburg-Eppendorf (UKE) have led the first randomized clinical trial with the new drug candidate favipiravir. The promising results have been published in the journal Nature Medicine.",
  "title": "Improving the treatment of Lassa fever: First clinical trial with favipiravir shows promising results"
}